Derek W. Ebner, M.D.

Location

Contact

SUMMARY

The research of Derek W. Ebner, M.D., aligns with his clinical expertise in gastrointestinal neoplasia. Dr. Ebner studies colorectal cancer prevention, the evaluation of premalignant conditions throughout the gastrointestinal tract and the management of hereditary cancer syndromes.

Focus areas

• Real-world colorectal cancer screening. Dr. Ebner leads some of the largest real-world studies evaluating stool-based colorectal cancer screening using multitarget stool DNA testing. His research also includes health economics and outcomes analyses. This approach helps inform evidence-based colorectal cancer screening strategies and optimize population-level impact.
• Premalignant conditions. Dr. Ebner explores artificial intelligence-enabled solutions to enhance quality monitoring and reporting of neoplasia detection during endoscopy. The goal is to improve diagnostic accuracy and procedural performance.

Significance to patient care

Colorectal cancer is one of the most common cancers and a leading cause of cancer deaths. It can often be prevented with the right screening tests, but about 1 in 3 people who should be screened do not get tested. Dr. Ebner's research looks at why people do or do not complete screening and follow-up care. His work helps improve testing and patient outcomes.

Dr. Ebner and his colleagues also study risk factors linked to precancerous conditions in the digestive tract. This work helps medical teams monitor patients more effectively, treat issues earlier and lower the chance of cancer.